In normal volunteers, serum free triiodothyronine (FT3) concentrations determined by Immophase FT3 RIA kit, Amerlex FT3 RIA kit and equilibrium dialysis methods (absolute FT3, AFT3: product of total T3 and percent FT3) were 4.03±0.65, 3.69±0.58 and 3.22±0.65 pg/ml ( mean + s.D. ), respectively. The normal free triiodothyronine index (FT3I) was 38.4+6.5. In patients with hyper-and hypothyroidism, the FT3 values measured by these methods were clearly abnormal. In patients with decreased thyroxine bindingglobulin, the mean FT3 concentrations determined by these methods were not significantly different from the normal. However, the mean FT3I was significantly lower than normal. In pregnant women at delivery, Amerlex FT3 values were subnormal in 7 of 9 subjects. All of these samples except one were within the normal range when evaluated by Immophase FT3 and AFT3, although their mean values were significantly lower than the mean of normal. On the other hand, the mean FT3I was not significantly different from the mean of normal. The correlations between FT3 values estimated by different methods and between FT3 values and FT3I were all statistically significant. In a clinically euthyroid patient who had chronic thyroiditis and who was shown to have anti-T3 antibody in her serum, Immophase FT3 and Amerlex FT3 values were above the high standards. However, AFT3, calculated by multiplying total T3 (determined after ethanol extraction) by percent FT3 was normal. In conclusion, the evaluation of FT3 by these radioimmunoassay methods proved clinically useful, when appropriate limitations are considered. free T3 ; radioimmunoassay ; equilibrim dialysis
Almost all of the circulating triiodothyronine is bound to thyroxine-binding proteins (TBP), mainly thyroxine-binding globulin (TBG), and the unbound T3 (free T3, FT3) constitutes only a minute portion of total T3 (TT3 ). It is well known that FT3 plays a major role as the biologically active hormone status, and that the serum level of FT3 reflects thyroid status more accurately than TT3 (Ingbar and Freinkel 1960) . The serum FT3 concentration has been determined by multiplying TT3 by percent FT3 fraction measured by equilibrium dialysis (Ingbar et al. 1965; Nauman et al. 1967 ), gel filtration (Scriba et al. 1966) or ultrafiltration (Pedersen 1974a ). However, these methods are unsuitable for routine work, because they are complicated and time consuming. Recently, new methods for the estimation of FT3 by radioimmunoassay (RIA) have been developed. We evaluated two commercial kit methods for FT3 (Immophase FT3 RIA and Amerlex FT3 RIA kits), and compared the results with those obtained by an equilibrium dialysis method (AFT3) and with free triiodothyronine index (FT3I) in various thyroid status.
MATERIALS AND METHODS
Sera were obtained from 61 euthyroid subjects, 29 hyperthyroid and 15 hypothyroid patients, 15 pregnant women at delivery, 6 patients with decreased TBG and one clinically euthyroid patient with chronic thyroiditis who had anti-T3 antibody in her serum.
Immophase FT3 kit method
The Immophase FT3 RIA kit (Corning Medical) is a kinetic method, using 2 tubes "A" and "B". In the "A" tube, 1251-T3 is equilibrated with 50,u1 of test serum for 20 min at room temperature.
In the "B" tube, 501 of test serum are incubated with 1251-T3 for 20 min at room temperature in the presence of 8-anilino-l-naphthalenesulfonic acid (ANS) which inhibits the binding of T3 to TBG. After equilibration, 800,1 of the T3-antibody, covalently bound to porous glass particles, are added to both "A" and "B" tubes, which are then incubated for an additional 60 min at room temperature.
In the "A" tube, the kinetics of binding of free 1251-T3 to T3 antibody is determined.
In the "B" tube, which is used to determine TT3, there is a competition between 1251-labeled and unlabeled T3 for a limited number of antibody binding sites. Bound and free tracer in both the "A" and "B" tubes are separated by centrifugation for 10 min at 1,400 x g. The ratio of cpm bound in the "A" tube to total count (Tc) in the "A" tube (A/Tc) yields the amount of T3 bound during the reaction, as a fraction of TT3 concentration of the sample. FT3 concentration of test serum is estimated from A/Tc x TT3 against a standard curve ).
Amerlex FT3 kit method
The Amerlex FT3 RIA kit (Amersham International) employs 1251-T3 derivative, which has been chemically modified to inhibit their binding to TBP, but which bind normally to T3-antibodies (Stevens et al. 1982) . Therefore, FT3 concentration can be measured in the presence of alterations in endogenous TBG. Moreover, because of the high affinity of anti-T3 antibody for T3, a small amount of antibody in this system has minimized its effect on the equilibration between T3 and TBP.
One hundred ,ul of test serum are incubated with the tracer and 500,u1 of T3-antibody in the test tube for 2 hr at 37°C. Free and bound are separated by centrifugation at 1,500 x g for 15 min. Bound is used for the determination of FT3 concentration ).
Equilibrium dialysis method Percent FT3 is obtained by an equilibrium dialysis method previously described (Ingbar et al. 1965; Yoshida et al. 1982) . Four ml of test serum diluted to 1: 8 with 0.15 M phosphate buffer, pH 7.4 containing tracer amount of 125I-T3 in Visking tube were dialyzed against 6 ml of the same buffer for 16-20 hr at 37°C. Three hundred,ul of pooled sera as T3 carrierr were added to one ml aliquot of dialysate or 100 ,u l of dialysand in 900 ,u 1 of the buffer in the counting tube. Addtion of 1.3 ml of 20% trichloracetic acid (TCA) to them resulted in the precipitation of T3 bound to proteins. The precipitates were washed with 5% TCA to remove non-T3 activities, and then counted. Percent FT3 was calculated as follows (Oppenheimer et al. 1963 ) %FT3 = (10 x Out)/(6 x Outs 4 x In) x 1/D x 100 where Out=cpm of precipitable 125I-T3 per ml of dialysate In = cpm of precipitable 125I-T3 per ml of dialysand D = dilution factor; 20 AFT3 was calculated by multiplying %FT3 by TT3 concentration determined by Immophase RIA kit.
Free triiodothyronine index (FT3I )
FT3I was calculated as the product of TT3 measured by Immophase RIA kit and resin T3 uptake (Triosorb test, Dainabot Co.).
Serum total T3 determination after ethanol extraction
One hundred ,u 1 of test serum were mixed with 300 1u l of 99% ethanol by a vortex mixer and were allowed to stand for 60 min at 22°C. The supernatant after centrifugation at 1,000 x g for 10 min was evaporated and then dissolved into 100 ,ul of T3 free serum. Total T3 of the sample was determined by Dainabot T3 RIA kit.
Serum TBG concentration
Serum TBG concentration was determined by RIA-gnost TBG kit (Hoechst Co.).
STATISTICAL ANALYSIS
Measured values are given in terms of mean +S.D, unless otherwise stated. Statistical comparisons of FT3 and FT3I values were carried out using Student's t-test. Correlation coefficients (r) were calculated by the least mean squares method.
RESULTS
The mean serum FT3 concentrations measured by the three methods, FT3I and serum TBG concentrations in various clinical states are presented in Table 1 . In the calculation of the mean value of FT3 in hyperthyroidism, all data exceeding the upper limit of the high standard were treated as if they were equal to the limit values. In hypothyroidism, the data below the lowest standard were treated analogously. The upper limit of the measurement in Amerlex kit method was higher (25 pg/ml) than that in Immophase kit method (21 pg/ml) ; almost all FT3 values in patients with untreated hyperthyroidism were above both upper limits.
Normal subjects
Defined as the mean+2 s.v., the normal ranges of FT3 for the Immophase, Amerlex and equilibrium dialysis methods were 2.73-5.33, 2.53-4.85 and 1.92-4.52 pg/ml, respectively. The normal range of FT3I was 25.4-51.4.
Patients with hyper-and hypothyroidism FT3 values determined by the Immophase, Amerlex and equilibrium dialysis methods were higher than 9.09, 11.60 and 4.92 pg/ml in hyperthyroid and lower than 1.49, 1.60 and 1.24 pg/ml in hypothyroid patients, respectively. FT3I values were over 92.6 in hyperthyroid and less than 18.1 in hypothyroid patients. There was no overlap of values between hyper-and hypothyroid patients by any methods and those in normal subiects.
Patients with decreased TBG
The mean TBG value of patients with decreased TBG was 4.5+4.3,ug/ml, as compared to that of the normal, 22.6 + 4.5 ,u g/ml. Mean FT3 values of patients with decreased TBG determined by the Immophase, Amerlex and equilibrium dialysis methods were 3.77 ±0.74, 3.63 ±0.69 and 2.75±0.35 pg/ml, respectively. The mean FT3 values in each method was not significantly different from the respective normal mean values. In addition, each FT3 value was within its respective normal ranges. However, the mean FT3I, 31.5±4.1, was significantly lower than normal, 38.4±6.5 ( Fig. 1) .
Pregnant women at delivery
The mean TBG value in pregnant women at delivery was 30.0+5.7 pg/ml and was significantly higher than normal.
By the Imrnophase assay, the FT3 values ranged from 2.30 to 3.99 pg/ml and the mean value was significantly lower than that in the control (p <0.005). However, all values except one were within the normal range.
By the Amerlex assay, the FT3 values ranged from 1.30 to 3.06 pg/ml and the mean value was also significantly lower than that of the control (p <0.001). Moreover, the FT3 values in seven of nine pregnant women were lower than the lowest value of the normal range, two of them even being within the hypothyroid range (Fig. 2) .
The AFT3 values ranged from 2.03 to 3.30 pg/ml with no sample subnormal, but the mean value was significantly lower than that of the normal ( Table 1) . The FT3I ranged from 30.0 to 46.5 and the mean value was not significantly different from the normal. A/Tc was decreased with the increase of TBG concentration, and was apparently high at the TBG concentration below 10 pl/ml. 
Anti-T3 antibody positive patient
In a clinically euthyroid patient who had chronic thyroiditis and who had anti-T3 antibody in her serum, serum TT3 concentration measured by Dainabot T3 RIA kit was not detectable and FT3 values by Immophase and Amerlex assays were beyond the upper limits of standard curves. TT3 determined by Dainabot T3 RIA kit after ethanol extraction was 776 ng/100ml, and %FT3 by equilibrium dialysis was 0.0345° . The calculated AFT3 value, 2.68 pg/ml, was within the normal range. and 
DISCUSSION
In healthy control subjects, the mean values of Immophase FT3, Amerlex FT3 AFT3 were 4.03±0.65, 3.69±0.58 and 3.22±0.65 pg/ml, respectively. The difference among these values could be ascribed to the substantial difference in the principles of these methods. For example, in a direct RIA kit method, anti-T3 antibody added to the serum affects the equilibration between endogenous T3 and T4-binding proteins. In the equilibrium dialysis method, the dilution of serum results in the decrease of %FT3 (Spaulding and Gregerman 1972) . However, the mean value of %FT3 (0.23%) obtained in the present study, is consistent with 0.26% reported by Sterling (1971) From these results, it seems to be difficult to determine the true value of FT3. Nevertheless, in the present study.. there were excellent correlations among FT3 values obtained by these three methods.
In the patients with hyper-and hypothyroidism, FT3 values estimated by these two RIA kits and the equilibrium dialysis methods and FT3I were all clearly separated from the normal ranges. FT3 values by these RIA kits in untreated hyperthyroidism were often beyond the upper limit of the measurement. But the dilution of serum is unsuitable for the determinatin of FT3, as the TBG concentration of the serum diluent is different from the patient samples. In fact, the dilution curves in these RIA kits did not coincide with the expected values when the sera were diluted with T3-free standard sera (data are not shown.). The values of A/Tc in Immophase FT3 kit method in hyperthyroid patients were not different from the normal values (Fig. 7) , which is different from %FT3 (Ingbar and Freinkel 1960) . Witherspoon et al. (1980) observed the same phenomenon in Immophase FT4 RIA kit method. From these results, it appears that Immophase FT3 value in patients with hyperthyroidism would not be influenced by A/Tc, but mainly by TT3.
In patients with decreased TBG, reported AFT3 values were inconsistent (Dussault et al. 1973; Smals et al. 1981) , and Amerlex FT3 value was reported to be low (Franklyn et al. 1983 ). In the present study, however, all of the mean values of Immophase FT3, Amerlex FT3 and AFT3 were not significantly different from those of normal subjects. This may be due to the fact that A/Tc in Immophase FT3 kit method, like %FT3, has negative correlation with TBG concentration as shown in Fig. 6 , and there seemed to be no influence of TBG in Amerlex FT3. However, the mean FT3I was significantly lower than normal. The most likely reason for this difference is that the resin T3 uptake of serum with very high or low TBG concentration does not exactly reflect the TBG-binding capacity (Kaise et al. 1979 ). In pregnancy, Osathanondh et al. (1976) reported that AFT3 remained normal at mid and term pregnancy, and Yamamoto, et al. (1979) reported a slight elevation of AFT3 in the early stage of pregnancy. On the other hand, Baldet and Jaffiol (1980) observed that AFT3 was significantly lower in pregnancy than in normal. As shown in Fig. l and Table 1 , mean FT3 values at delivery determined by these three methods were significantly lower than normal. Therefore, it is conceivable that some reduction in FT3 concentration in pregnancy at delivery might not be a methodological artifact, but represents a true physiological change. Nevertheless, the Amerlex FT3 values tended to show a greater decrease in pregnancy. Amino et al. (1983) observed that estimated FT4 by Amerlex FT4 R.IA kit in pregnancy was decreased in parallel with the decrease in serum albumin concentration and that T4-derivative binds to albumin. We also observed that T3-derivative in Amerlex FT3 RIA kit binds to serum albumin ). These findings suggest that the decreased serum albumin concentration in pregnacy at delivery might cause a low FT3 value in Amerlex FT3 assay.
The present result showed that endogenous thyroid hormone-binding antibodies produce artificially abnormal result with RIA method that assays serum directly. When FT3 measured by RIA yields a very high value, not consistent with the clinical symptoms, anti-T3 antibody positive case should be ruled out by measuring AFT3 as the product of %FT3 by equilibrium dialysis and TT3 determined after the inactivation and removal of the immunoglobulin by ethanol extraction or Sephadex (William and Nicholas 1983) .
Both Amerlex and Immophase FT3 RIA kits have the advantages of simplicity and rapidity, and the values obtained in the present study showed excellent correlations with AFT3. Therefore, the two kits are clinically useful. But, careful attention should be paid for the interpretation of FT3 values in case showing a discrepancy between the FT3 value and clinical manifestations or other thyroid function tests.
